Literature DB >> 21325209

Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.

Andrew D Krahn1, Douglas S Lee, David Birnie, Jeffrey S Healey, Eugene Crystal, Paul Dorian, Christopher S Simpson, Yaariv Khaykin, Douglas Cameron, Amir Janmohamed, Raymond Yee, Peter C Austin, Zhongliang Chen, Judy Hardy, Jack V Tu.   

Abstract

BACKGROUND: Complications after implantable cardioverter-defibrillator (ICD) replacement are often clinically devastating, particularly when infection or reoperation occurs. Identifying factors contributing to complications may permit identification of high-risk individuals that warrant incremental monitoring and therapy to attenuate risk. In addition, replacement may be a discretionary decision in the context of an advisory or borderline device performance and patient, device, and implanter factors that predict adverse outcome may assist in clinical decision-making. METHODS AND
RESULTS: In a prospective, multicenter, population-based registry of all ICD patients at 18 centers in Ontario, Canada, we examined 45-day complication and all-cause mortality rates from February 2007 to August 2009 in patients undergoing ICD generator replacement. Complications were determined longitudinally and were categorized as major or minor. ICD replacement was performed in 1081 of 5176 patients (20.8%) undergoing ICD implantation (age, 64.3±12.7 years; 78.5% men). In patients undergoing ICD replacement, 47 patients (4.3%) had a complication within 45 days, with 47 major complications in 28 patients (2.6%), most commonly infection (n=23), lead revision (n=35), electrical storm (n=14), and pulmonary edema (n=13). Minor complications occurred in 2.3% of patients, most commonly incisional infection (n=10) and pocket hematoma (n=10). On multivariable analysis, risk factors associated with major complications were Canadian Cardiovascular Society angina class (adjusted hazard ratio [HR], 3.70 for class 2 to 4 versus 0 to 1; P=0.027) and multiple previous procedures on the pocket (adjusted HR, 3.35 for >1 versus 1; P=0.058). Risk factors associated with any complication were the use of antiarrhythmic therapy (adjusted HR, 6.29; P=0.001), implanter volume (adjusted HR 10.4 for <60/y versus >120/y, P=0.026), and Canadian Cardiovascular Society angina class (adjusted HR, 3.00 for class 2 to 4 versus 0 to 1; P=0.031). In a Cox model with a time-dependent variable of major complication within 45 days after replacement, major complications after ICD replacement were associated with an increased risk of mortality at 45, 90, and 180 days (adjusted HR, 9.61, 12.69, and 6.41, respectively; P=0.002 to 0.039).
CONCLUSIONS: Risk factors associated with complications after ICD replacement include the presence of angina, antiarrhythmic therapy, increased number of previous procedures, and low implanter volume. Major complications may be associated with increased risk of subsequent mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21325209     DOI: 10.1161/CIRCEP.110.959791

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  40 in total

1.  Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.

Authors:  Ashwani Gupta; Faiz Subzposh; Shelley R Hankins; Steven P Kutalek
Journal:  Tex Heart Inst J       Date:  2015-04-01

Review 2.  Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: A systematic review and meta-analysis.

Authors:  Emily P Zeitler; Divyang Patel; Vic Hasselblad; Gillian D Sanders; Sana M Al-Khatib
Journal:  Heart Rhythm       Date:  2015-04-03       Impact factor: 6.343

3.  Implantable cardioverter defibrillators: even better than we thought?

Authors:  Una Buckley; Kalyanam Shivkumar
Journal:  Eur Heart J       Date:  2015-05-05       Impact factor: 29.983

4.  Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.

Authors:  Malini Madhavan; Jonathan W Waks; Paul A Friedman; Daniel B Kramer; Alfred E Buxton; Peter A Noseworthy; Ramila A Mehta; David O Hodge; Angela Y Higgins; Tracy L Webster; Chance M Witt; Yong-Mei Cha; Bernard J Gersh
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

Review 5.  Decision-making under uncertainty in advanced heart failure.

Authors:  Theo E Meyer; Michael S Kiernan; David D McManus; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2014-06

6.  Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration.

Authors:  Klaus Bielefeldt
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

7.  Influence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement.

Authors:  Jonathan W Waks; Angela Y Higgins; Murray A Mittleman; Alfred E Buxton
Journal:  J Cardiovasc Electrophysiol       Date:  2015-01-07

8.  The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries.

Authors:  Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2015-02-19       Impact factor: 5.460

9.  Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.

Authors:  Jonathan W Waks; Christopher Hamilton; Saumya Das; Ashkan Ehdaie; Jessica Minnier; Sanjiv Narayan; Mark Niebauer; Merritt Raitt; Christine Tompkins; Niraj Varma; Sumeet Chugh; Larisa G Tereshchenko
Journal:  J Interv Card Electrophysiol       Date:  2018-03-14       Impact factor: 1.900

10.  Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?

Authors:  Vinay Kini; Mohamad Khaled Soufi; Rajat Deo; Andrew E Epstein; Rupa Bala; Michael Riley; Peter W Groeneveld; Alaa Shalaby; Sanjay Dixit
Journal:  J Am Coll Cardiol       Date:  2014-04-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.